FUJIF News and Press, FUJIFILM Holdings Corp From 11/07/22

Summary Carl Zeiss Meditec recorded strong order growth of 36% YoY in Q3 FY9/2022 results, highlighting strong underlying demand. Operating margins look stable at 20%, driven by an improving sales mix despite ongoing investment in R&D and marketing activities. The shares h...

The Carillon Family of Funds spans a range of investment objectives and asset classes designed for long-term investors. The U.S. stock and bond markets appear to be conveying different assessments of the outlook, leaving investors to decide which view will prevail. Focusing on how...

The Carillon Family of Funds spans a range of investment objectives and asset classes designed for long-term investors. The U.S. stock and bond markets appear to be conveying different assessments of the outlook, leaving investors to decide which view will prevail. The situation c...

Fujifilm Irvine Scientific (OTCPK:FUJIY) (OTCPK:FUJIF) is set to acquire recombinant proteins maker Shenandoah Biotechnology. Financial terms of the deal were not disclosed. The deal is expected to close later this month. Shenandoah Biotechnology is a privately held company located in Warmins...

Fujifilm Holdings has been acquiring companies while increasing its dividends and buying back its shares. Its EPS has more than doubled from 10 years ago and averages 14.1% growth since 2016. Its current market price trades below its book value price. In my opinion, this implies t...

winhorse/iStock Unreleased via Getty Images The newly appointed CEO of FUJIFILM Holdings Corporation (FUJIF), (FUJIY) Teiichi Goto, has outlined a three-year, $11B investment plan centered on the healthcare business to diversify the company away from the company’s original photo busine...

Fujifilm Medical Systems announces that the FDA has granted 510(k) clearance for Fujifilm’s (FUJIY) new image enhancement technology - the Oxygen Saturation Endoscopic Imaging System - which was developed to improve visualization during gastrointestinal, colorectal, and advanced endosc...

Fujifilm (FUJIY) will invest ~$850M in its core biopharmaceutical contract development and manufacturing organization ((CDMO)), Fujifilm Diosynth Biotechnologies.The investment will go towards increasing manufacturing and development capacity, including a twofold increase in cell culture prod...

Olympus is a leading medtech company that offers predictable earnings growth, an optimized portfolio and engages with activist investors to deliver better shareholder returns. Its medium-term plan to target operating margins of 20% plus looks achievable, highlighting the potential sco...

The Biden administration is being pressured to suspend the intellectual property of companies that have developed the COVID-19 vaccine and antibody therapies. The intellectual property possessed by companies that helped them develop a COVID-19 vaccine as well as antibody therapies off...